Restoril (temazepam) is not a narcotic. It is a benzodiazepine, a completely different class of drug that works through a different mechanism in the brain. The confusion is understandable because Restoril is a controlled substance with real potential for abuse and dependence, but it is pharmacologically and legally distinct from narcotics like oxycodone, morphine, or fentanyl.
What Restoril Actually Is
Restoril is classified as a “benzodiazepine hypnotic agent,” meaning it’s a sedative specifically used to help people fall and stay asleep. The FDA approves it for the short-term treatment of insomnia, generally 7 to 10 days. Its safety and effectiveness beyond two weeks have not been established.
The DEA classifies Restoril as a Schedule IV controlled substance. Narcotics (opioids) like oxycodone and hydrocodone are typically Schedule II, reflecting a higher potential for abuse. Schedule IV drugs can still lead to dependence and misuse, but they carry a lower risk profile than Schedule II substances.
Why People Confuse It With a Narcotic
The word “narcotic” gets used loosely. In everyday conversation, people often use it to mean any controlled or potentially addictive drug. In medical and legal terms, narcotics refer specifically to opioids, which are drugs derived from or designed to mimic opium. Restoril doesn’t belong to that family at all.
Both benzodiazepines and opioids can cause sedation, both carry dependence risks, and both are regulated by the DEA. That overlap in reputation leads to the mix-up. But the drugs act on entirely different systems in the brain, produce different effects, and pose different risks.
How Restoril Works in the Brain
Narcotics bind to opioid receptors (called mu receptors) to block pain signals and produce euphoria. Restoril does neither of those things. Instead, it enhances the effect of GABA, the brain’s primary calming chemical. Temazepam increases GABA’s ability to bind to its receptors, which makes brain cells less excitable. The result is sedation, muscle relaxation, and reduced anxiety, all of which help with falling asleep.
This distinction matters for more than just classification. Because the two drug types work on completely separate receptor systems, combining them is especially dangerous. Each one depresses the central nervous system through its own pathway, so together they can slow breathing to a life-threatening degree.
The Danger of Mixing Restoril With Opioids
Restoril’s FDA label carries a boxed warning, the most serious type, about combining benzodiazepines with opioids. Taking both together can cause profound sedation, dangerously slowed breathing, coma, and death. Observational studies have shown that using opioid painkillers alongside benzodiazepines increases the risk of drug-related death compared to using opioids alone.
If you’re prescribed Restoril and you also take any opioid medication, your prescriber should be aware of both. The risk isn’t theoretical. It’s one of the most well-documented dangerous drug interactions in modern medicine.
Dependence and Withdrawal Risks
Even though Restoril isn’t a narcotic, it shares one important trait with opioids: your body can become physically dependent on it. Physical dependence means your system adapts to the drug’s presence. If you stop suddenly or reduce the dose too quickly, a withdrawal syndrome can follow. That’s one reason Restoril is approved only for short-term use.
The FDA label distinguishes between physical dependence and addiction. Dependence is a predictable biological adaptation. Addiction involves compulsive use, loss of control, and continued use despite harm. Both can occur with Restoril, but dependence is far more common, particularly when someone takes it nightly for longer than the recommended 7 to 10 days. Tolerance, where the same dose becomes less effective over time, can also develop and lead people to take more than prescribed.
How Restoril Compares to Narcotics at a Glance
- Drug class: Restoril is a benzodiazepine. Narcotics are opioids.
- Brain target: Restoril enhances GABA activity. Narcotics bind to mu opioid receptors.
- Primary use: Restoril treats insomnia. Narcotics treat moderate to severe pain.
- DEA schedule: Restoril is Schedule IV (lower abuse potential). Most narcotics are Schedule II.
- Dependence risk: Present with both, but generally develops faster and more severely with opioids.
- Overdose mechanism: Both can slow breathing to dangerous levels, especially when combined with each other or with alcohol.
What This Means for Drug Testing
Standard drug tests screen for benzodiazepines and opioids as separate categories. If you take Restoril, you will likely test positive for benzodiazepines, not for opioids or narcotics. These are distinct panels on a drug screen. Having a valid prescription typically explains a positive benzodiazepine result, but it’s worth disclosing your medications beforehand if you know a test is coming.